Authors:
Kiran Pulidindi, Alish Bodar
Download free PDF
Pet Food Protein Hydrolysates Market Size & Share 2026-2035
Report ID: GMI15322
|
Published Date: November 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Pet Food Protein Hydrolysates Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
Pet Food Protein Hydrolysates Market Size
The pet food protein hydrolysates market was valued at USD 1.70 billion in 2025, is projected to reach USD 1.80 billion in 2026, is expected to expand at a 5.50% CAGR (2026-2035), and is forecast to reach USD 2.91 billion by 2035. The market covers commercially produced hydrolysate ingredients supplied to pet food manufacturers for dry and wet food, treats, supplements, therapeutic diets, and palatability applications.
Pet Food Protein Hydrolysates Market Key Takeaways
Market Leader: Symrise Pet Food led with over 13.50% market share in 2025.
Leading Players: Top 5 players in this market include Symrise Pet Food, Kemin Industries, Darling Ingredients (Sonac Brand), GELITA, Rousselot, which collectively held a market share of 52% in 2025.
The pet food protein hydrolysates market is moving beyond commodity digest applications toward specified functional ingredients. Demand increasingly reflects the need for controlled molecular-weight profiles, lower residual antigenicity, and bioactive peptide functionality in hypoallergenic, therapeutic, and life-stage formulations. This change favors suppliers that can combine process control, regulatory documentation, and consistent formulation support.
GMI Analyst View
Our discussions with industry experts confirm that global consumption of pet food protein hydrolysates reached 471 kilotons by volume in 2025, underscoring the ingredient category's material penetration across both mainstream and premium pet food formats. We see this volume base as evidence that future value creation will depend increasingly on differentiated peptide functionality, specification control, and clinical relevance rather than undifferentiated inclusion-rate expansion.
Pet Food Protein Hydrolysates Market Trends, Growth Drivers & GMI Forecast Outlook
Premium pet nutrition, veterinary-led formulation, and demand for differentiated protein inputs are reshaping procurement priorities across the hydrolysate supply chain. Forecast performance depends on the ability of suppliers to translate protein-source innovation and process control into documented functional outcomes while managing raw-material transitions and compliance requirements.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
The scale of U.S. pet nutrition spending supports continued premium formulation activity, particularly where manufacturers can defend higher ingredient costs through digestive-health, allergen-management, or veterinary nutrition positioning. Hydrolysates are increasingly purchased as targeted functional systems rather than interchangeable flavor inputs, supporting demand for tightly controlled enzymatic fractions.
Ingredient specialization also broadens the commercial pathways available to hydrolysate suppliers. Formulators can deploy differentiated peptide profiles across palatability, digestibility, supplement, and therapeutic formats, creating a more diverse demand base than that available to conventional protein meals. The opportunity is strongest where suppliers can align technical documentation with application-specific formulation support.
Regulatory recognition of hydrolyzed protein ingredients has particular importance for elimination diets and food-responsive dermatological or gastrointestinal nutrition. It allows veterinary and therapeutic channels to scale without treating every formulation as a bespoke technical proposition, while increasing the value of suppliers with robust allergenicity and molecular-weight characterization.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
The shift away from conventional animal meals and fats does not remove demand for protein hydrolysates; it changes the raw-material and product-profile requirements attached to that demand. Suppliers dependent on undifferentiated rendered protein streams face more pressure than companies able to offer collagen, plasma, fish, or other fractions with clear functional relevance.
Europe illustrates the distinction between stable value demand and limited volume momentum. In this environment, buyers prioritize efficacy per gram, formulation reliability, and clinical documentation over broad inclusion-rate expansion. The regional opportunity therefore favors hydrolysates that solve a defined palatability, digestibility, or allergen-management problem.
Compliance requirements create a meaningful barrier in therapeutic applications because partial hydrolysis alone does not establish a defensible hypoallergenic position. Suppliers need repeatable characterization, traceability, and cross-reactivity documentation, which favors established processors and raises the qualification burden for new capacity.
GMI Analyst View
We view the forecast as a mix-led growth cycle rather than a broad-based volume expansion story. Clinical specificity, novel protein processing, and constrained mainstream volume growth in parts of Europe point to value creation in therapeutic, ultra-low-molecular-weight, and differentiated-source grades. The principal risks concern the timing of supply qualification and regulatory execution, not the direction of end-use demand.
Pet Food Protein Hydrolysates Market Segment Analysis
By Technology
Enzymatic hydrolysates held a 55.00% market share in 2025 and are projected to reach USD 1.45 billion by 2035. Their lead reflects the ability of enzyme-led processes to control peptide distribution and preserve functionality for hypoallergenic, digestibility, and therapeutic formulations. Acid hydrolysates generated USD 341.20 million in 2025 and are projected to hold 16.00% of the market by 2035; they remain relevant in cost-sensitive palatability applications but face a narrower role where molecular-weight precision is required.
Alkaline hydrolysates held a 10.00% share in 2025 and are projected to reach USD 262.26 million by 2035. Their utility in solubilizing plant and selected marine proteins supports demand where process economics matter, although their role often complements later enzymatic finishing. Thermal & pressure hydrolysates accounted for 8.00% in 2025 and are expected to hold 11.00% by 2035, benefiting from operational fit with marine by-products and emerging insect-protein processing.
Microbial & fermentation hydrolysates were valued at USD 119.42 million in 2025 and are projected to reach USD 407.96 million by 2035. This route is positioned around novel protein structures, sustainability narratives, and fermentation-enabled functionality, but commercialization depends on regulatory readiness, scale-up discipline, and customers' willingness to qualify new processing platforms.
By Protein Source
Animal protein hydrolysates held a 48.00% share in 2025 and are projected to reach USD 1.25 billion by 2035. Established rendering, plasma, collagen, and poultry supply chains give this category a durable procurement base, although its relative position is being reshaped by demand for more differentiated protein origins.
Fish & marine protein hydrolysates generated USD 477.68 million in 2025 and are projected to grow at a 5.12% CAGR (2026-2035). Their commercial appeal combines strong palatability performance with relevance to single-protein and hypoallergenic formulations, particularly in wet cat food and premium therapeutic diets. Plant protein hydrolysates held a 15.00% share in 2025 and are projected to reach USD 524.52 million by 2035, supported by pea, soy, wheat, corn, and potato-based formulation strategies in dry food and limited-ingredient products.
Insect-derived protein hydrolysates held a 3.00% share in 2025 and are projected to reach USD 203.98 million by 2035. Their expansion depends on commercial-scale substrate availability, regulatory acceptance, and whether black soldier fly and mealworm platforms can consistently meet pet food manufacturers' cost, traceability, and functional-performance requirements.
By Molecular Weight
Ultra-low molecular weight fractions held a 12.00% share in 2025 and are projected to hold 18.00% by 2035. Their growth reflects demand for highly characterized bioactive peptide inputs in therapeutic, supplement, and advanced allergen-management applications, where technical barriers to production can support pricing differentiation.
Low molecular weight fractions were valued at USD 597.10 million in 2025 and are projected to hold 33.00% of the market by 2035. These grades remain central to hypoallergenic elimination diets because dependable fraction control and batch-level allergenicity documentation are critical to veterinary and clinical formulation use. Medium molecular weight fractions held a 38.00% share in 2025 and are projected to reach USD 1.01 billion by 2035, reflecting their broad use in palatability, savory peptide delivery, and digest-coating applications.
High molecular weight fractions held a 15.00% share in 2025 and are projected to grow at a 4.77% CAGR (2026-2035). They retain an important role in wet food matrices, collagen-structured treats, and functional protein contribution, but their residual antigenic potential limits their fit in hypoallergenic positioning.
By Application
Dry pet food generated USD 511.80 million in 2025 and is projected to hold 27.00% of the market by 2035. The segment remains the foundational procurement channel for spray-coating, palatability, and digestibility applications, although its relative share moderates as specialized formats expand.
Wet pet food held a 25.00% share in 2025 and is projected to reach USD 670.22 million by 2035. Its aqueous processing environment favors liquid hydrolysates and marine-derived fractions that contribute aroma, savory delivery, and nutrient dispersion. Pet treats & chews accounted for 18.00% in 2025 and are projected to grow at a 6.07% CAGR (2026-2035), as functional treat formats provide an accessible delivery vehicle for joint, skin, coat, dental, and gastrointestinal positioning.
Pet food supplements were valued at USD 170.60 million in 2025 and are projected to reach USD 349.68 million by 2035. Supplement demand is extending hydrolysate use beyond conventional food formats into peptide-led life-stage, gut-health, and recovery-oriented products. Therapeutic & veterinary diets held a 12.00% share in 2025 and are projected to reach USD 407.96 million by 2035, supported by the need for clinically documented molecular-weight, allergenicity, and functional-performance specifications.
By Form
Powder held a 60.00% share in 2025 and is projected to reach USD 1.63 billion by 2035. Spray-dried and freeze-dried grades align with dry food manufacturing, shelf-life needs, and controlled ingredient metering, making powder the most operationally flexible form for large-scale formulation.
Liquid forms held a 30.00% share in 2025 and are projected to reach USD 961.62 million by 2035. Their homogeneous dispersion supports wet food, gravy, coating, and direct-application formats where soluble peptide delivery and aroma performance are important. Paste hydrolysates accounted for 10.00% in 2025 and are projected to hold 11.00% by 2035, with use concentrated in soft chews and functional treats that require controlled viscosity and palatability contribution.
By Pet Type
Dogs generated USD 955.36 million in 2025 and are projected to hold 54.00% of the market by 2035. The scale and diversity of canine nutrition, from puppy and adult food to senior, hypoallergenic, and mobility formats, sustain demand for differentiated hydrolysate specifications.
Cats are projected to reach USD 1.13 billion by 2035 and are expected to grow at a 5.77% CAGR (2026-2035). Wet-food orientation, preference for animal and marine flavor systems, and expanding senior-cat nutrition create a favorable setting for fish-derived, animal-derived, and amino-acid-rich hydrolysate grades. Other pet types held a 6.00% share in 2025 and are projected to reach USD 203.98 million by 2035, as specialized nutrition for small mammals, birds, and exotic pets attracts more targeted formulation investment.
GMI Analyst View
We see segment leadership shifting toward platforms that can combine functional performance with defensible technical documentation. Enzymatic processing remains the commercial anchor, but fermentation, insect-derived inputs, ultra-low-molecular-weight fractions, and therapeutic applications are expanding the margin pool. Suppliers that can operate across process routes and validate application outcomes should be better positioned than companies competing primarily on palatability cost.
Pet Food Protein Hydrolysates Market Regional Analysis
North America Pet Food Protein Hydrolysates Market Analysis
North America held a 37.00% share of the pet food protein hydrolysates market in 2025 and is projected to reach USD 990.76 million by 2035. The region combines mature premium pet food channels, veterinary nutrition infrastructure, and a deep ingredient supply base, creating demand for hydrolysates with documented digestibility, palatability, and hypoallergenic performance.
United States
The United States generated USD 536.54 million in 2025 and is projected to hold a 28.56% global share by 2035. Its veterinary prescription channels, premium retail formats, and direct-to-consumer nutrition models create a layered demand base for qualified hydrolysate inputs. U.S. pet food and treat spending also provides a substantial downstream market for ingredient innovation [1]American Pet Products Association. "U.S. Pet Industry Reaches $158 Billion in 2025, Poised for Continued Growth in 2026." americanpetproducts.org.
Europe Pet Food Protein Hydrolysates Market Analysis
Europe generated USD 460.62 million in 2025 and is projected to hold 24.00% of the market by 2035. Its outlook is shaped by sophisticated compliance requirements, established collagen and gelatin processing capacity, and a value-led rather than volume-led pet food environment. FEDIAF's reported volume growth underscores the importance of precision-function and therapeutic positioning over broad inclusion-rate growth [3]FEDIAF - European Pet Food Industry Federation. "Annual Report 2026 - Facts & Figures 2024." europeanpetfood.org.
Germany
Germany generated USD 115.16 million in 2025 and is projected to hold a 5.76% global share by 2035. The country's premium pet food market and advanced use of veterinary diet formats reinforce demand for enzymatic and low-molecular-weight hydrolysates, while German quality and labeling expectations influence broader European procurement standards.
United Kingdom
The United Kingdom held a 5.40% global share in 2025 and is projected to reach USD 132.88 million by 2035. Its premium-oriented pet nutrition market supports continued use of characterized hydrolysates, although suppliers must navigate a distinct post-Brexit compliance environment alongside evolving product-development requirements.
France
France held a 4.59% global share in 2025 and is projected to hold 3.60% by 2035. The country remains strategically important to collagen and gelatin supply, with its rendering and ingredient-processing base supporting functional peptide applications across European pet nutrition markets.
Asia Pacific Pet Food Protein Hydrolysates Market Analysis
Asia Pacific is projected to grow at a 7.08% CAGR (2026-2035) and reach USD 845.06 million by 2035. The pet food protein hydrolysates market in the region benefits from pet ownership growth, expanding premium retail, digital access to veterinary nutrition information, and a faster transition toward functional product positioning in major urban markets.
China
China held a 10.00% global share in 2025 and is projected to reach USD 354.93 million by 2035. Domestic manufacturers are broadening ingredient sourcing for premium and therapeutic lines as pet ownership and veterinary nutrition awareness expand beyond top-tier cities.
Japan
Japan generated USD 76.77 million in 2025 and is projected to hold a 4.35% global share by 2035. Its mature pet food market, preference for marine-origin ingredients, and aging companion-animal population support demand for fish, collagen, and amino-acid-focused hydrolysates in wet food and senior-pet nutrition.
South Korea
South Korea held a 3.00% global share in 2025 and is projected to reach USD 92.96 million by 2035. High engagement with premium, functional, and imported pet food formats creates a receptive market for differentiated hydrolysate-containing products and specialized ingredient claims.
India
India held a 2.50% global share in 2025 and is projected to grow at a 9.05% CAGR (2026-2035). Urban pet adoption, expanding veterinary access, and the early development of domestic premium pet food production create substantial upside, although the pace of formulator investment and distribution development will determine near-term conversion.
Latin America Pet Food Protein Hydrolysates Market Analysis
Latin America generated USD 119.42 million in 2025 and is projected to reach USD 233.12 million by 2035. Expanding pet ownership and premium food adoption are supported by regional rendering and animal by-product infrastructure, particularly in Brazil, which can reduce dependence on imported animal-protein inputs.
Brazil
Brazil held a 3.85% global share in 2025 and is projected to reach USD 128.22 million by 2035. As the region's largest pet food market, it provides a natural demand center for animal, fish, and functional hydrolysate ingredients, particularly as cat food and premium therapeutic formats gain relevance.
Middle East & Africa Pet Food Protein Hydrolysates Market Analysis
Middle East & Africa held a 4.00% global share in 2025 and is projected to hold 5.00% by 2035. Growth is supported by urban pet culture, premium retail expansion, and import-led access to European and North American pet food formulations containing specified hydrolysate ingredients.
Saudi Arabia
Saudi Arabia generated USD 19.11 million in 2025 and is projected to reach USD 42.25 million by 2035. Demand is increasingly tied to premium retail and veterinary nutrition formats, with hydrolysate adoption largely entering through imported and internationally formulated pet food products.
United Arab Emirates
The United Arab Emirates generated USD 15.01 million in 2025 and is projected to reach USD 33.51 million by 2035. Its affluent urban consumer base and developed specialty retail environment make it an early-adoption market for functional and therapeutic pet food formats in the region.
South Africa
South Africa held a 1.00% global share in 2025 and is projected to reach USD 34.97 million by 2035. Its comparatively developed pet food and veterinary nutrition ecosystem provides an entry point for differentiated hydrolysate applications across sub-Saharan distribution networks.
GMI Analyst View
We believe regional growth is progressively challenging a supply model centered on North America and Europe. Asia Pacific offers the strongest strategic expansion potential because domestic manufacturers are still building premium formulation capabilities and supplier relationships. At the same time, the opportunity requires patient qualification, local channel development, and product specifications calibrated to emerging-market purchasing behavior.
Pet Food Protein Hydrolysates Market Share & Competitive Landscape
The pet food protein hydrolysates market is moderately concentrated, with the five leading suppliers collectively holding approximately 52% of the market in 2025. Market share reflects process-engineering capabilities, raw-material access, formulation support, and the ability to document molecular-weight and allergenicity performance for higher-value therapeutic and clinical applications.
Symrise Pet Food held a 13.50% market share in 2025 and is strengthening its position in premium marine hydrolysates through its partnership with Hofseth BioCare. The arrangement links Symrise's pet nutrition channels with salmon-derived bioactive ingredient capacity and supports a broader move toward differentiated marine and hypoallergenic inputs [4]Symrise AG. "Symrise Accelerates in Human Health and Pet Nutrition Through a Strategic Partnership with HBC." symrise.com.
Kemin Industries held an 11.00% market share in 2025. Its pet nutrition platform combines palatability and hydrolysate expertise with digestibility and hypoallergenic application support, while the acquisition of Bactana adds adjacent fermentation and postbiotic capabilities relevant to companion-animal gut health [6]Kemin Industries. "Kemin Industries Expands Innovation in Intestinal Health with Strategic Acquisition." prnewswire.com.
Darling Ingredients, through the Sonac brand, held a 10.50% market share in 2025. Its animal by-product and blood-protein processing footprint gives it structural access to core hydrolysate feedstocks, while Rousselot broadens the group's position in collagen peptide and functional protein applications [5]Darling Ingredients Inc. "Annual Report / Form 10-K 2024." darlingii.com.
GELITA and Rousselot are significant participants in collagen and gelatin hydrolysate categories, where joint health, mobility, senior pet nutrition, and functional treat formats create a distinct value pool. PB Leiner's global collagen and gelatin infrastructure further increases competitive intensity in these specialized peptide applications. Marine specialists such as Copalis Sea Solutions and Hofseth BioCare compete on species traceability and premium functional positioning, while Protix and Innovafeed represent the emerging insect-protein pathway. Cargill, APC Global, Veos Group, Bioiberica, and MBRF Ingredients bring scale or specialist capabilities in animal, plasma, biomolecule, and functional protein supply.
Recent Industry Developments
In May 2025, Kemin Industries acquired Bactana Corp through Kemin Nutrisurance. The transaction adds postbiotic and fermentation-related intellectual property relevant to intestinal health and companion-animal nutrition, strengthening Kemin's capability set around microbial and functional ingredient development [6]Kemin Industries. "Kemin Industries Expands Innovation in Intestinal Health with Strategic Acquisition." prnewswire.com.
In May 2025, Darling Ingredients and Tessenderlo Group announced a proposed combination of Rousselot and PB Leiner collagen and gelatin businesses under the Nextida brand, subject to regulatory approvals. If completed, the transaction would materially alter the supply landscape for collagen peptides and gelatin-based functional ingredients used in pet nutrition [7]NutritionInsight. "Rousselot and PB Leiner to Combine Collagen and Gelatin Know-How in New Nextida Company." nutritioninsight.com.
In February 2025, Symrise and Hofseth BioCare established a strategic partnership to expand production and market access for marine protein hydrolysates. The partnership connects premium salmon-derived ingredients with Symrise's commercial reach in pet nutrition and supports additional hydrolysis capacity in Norway [4]Symrise AG. "Symrise Accelerates in Human Health and Pet Nutrition Through a Strategic Partnership with HBC." symrise.com.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →